Yarlagadda S. Babu
2019
In 2019, Yarlagadda S. Babu earned a total compensation of $1.1M as Senior Vice President of Drug Discovery at BioCryst Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $147,084 |
|---|---|
| Option Awards | $489,623 |
| Salary | $432,600 |
| Other | $14,000 |
| Total | $1,083,307 |
Babu received $489.6K in option awards, accounting for 45% of the total pay in 2019.
Babu also received $147.1K in non-equity incentive plan, $432.6K in salary and $14K in other compensation.
Rankings
In 2019, Yarlagadda S. Babu's compensation ranked 8,920th out of 13,971 executives tracked by ExecPay. In other words, Babu earned more than 36.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,920 out of 13,971 | 36th |
Division Manufacturing | 3,567 out of 5,701 | 37th |
Major group Chemicals And Allied Products | 1,349 out of 2,200 | 39th |
Industry group Drugs | 1,150 out of 1,886 | 39th |
Industry Biological Products, Except Diagnostic Substances | 260 out of 389 | 33rd |
Source: SEC filing on March 31, 2020.
Babu's colleagues
We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2019.
2019
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2019
Megan Sniecinski
BioCryst Pharmaceuticals
Senior Vice President and Chief Business Officer
2019
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2019
Thomas Staab
BioCryst Pharmaceuticals